Serridic Tablets combine an NSAID with an enzyme preparation to support the management of pain, inflammation and associated swelling.
Key Features
- Contains Diclofenac Potassium 50 mg for pain and inflammation relief.
- Contains Serratiopeptidase 10 mg, equivalent to 20,000 units of enzymatic activity.
- Helps provide relief from pain, inflammation and swelling.
- Useful in the symptomatic management of various musculoskeletal and inflammatory conditions.
- Enteric-coated formulation designed for oral administration as prescribed by a healthcare professional.
Composition
Each enteric-coated tablet contains:
- Diclofenac Potassium BP – 50 mg
- Serratiopeptidase IP – 10 mg
(Equivalent to 20,000 units of enzymatic activity) - Excipients – q.s.
- Colour: Red Oxide of Iron
Indication
Serridic Tablets are indicated for the symptomatic relief of pain, inflammation and swelling associated with musculoskeletal disorders, injuries, postoperative conditions and other inflammatory conditions, as directed by a qualified healthcare professional.
